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TO THE EDITOR
Collagen XVII, also referred to as the
180 kDa bullous pemphigoid antigen
(BP180), is a hemidesmosomal trans-
membrane protein targeted by auto-
reactive T and B cells in pemphigoid
diseases, such as bullous pemphigoid
(BP), pemphigoid gestationis, and
mucous membrane pemphigoid (Sitaru
and Zillikens, 2005; Mihai and Sitaru,
2007). The pathogenicity of autoanti-
bodies against collagen XVII is suppor-
ted by extensive clinical and experi-
mental evidence (Sitaru and Zillikens,
2005). The membrane-proximal non-
collagenous NC16A region of collagen
XVII harbors both major pathogenic
epitopes of the autoimmune response
in BP and pemphigoid gestationis, and
the proteolytic cleavage site(s) involved
in the shedding of its 120 kDa extra-
cellular domain (Giudice et al., 1993;
Matsumura et al., 1996; Franzke et al.,
2002).
We recently showed that the NC16A
domain is extracellularly phosphory-
lated by ecto-casein kinase 2 (CK2) at
residue Ser544 (Figure 1a) and that
phosphorylation of collagen XVII is
functionally involved in the regulation
of ectodomain shedding (Zimina et al.,
2007). Post-translational protein mod-
ifications, such as phosphorylation,
have been shown to influence antigen
recognition by autoantibodies in other
autoimmune diseases, for example,
multiple sclerosis or systemic lupus
erythematosus (van Stipdonk et al.,
1998; Doyle and Mamula, 2001;
Anderton, 2004). Therefore, it is of
interest to assess the pathogenic rele-
vance of post-translational modifica-
tions of collagen XVII in BP. In this
study, we followed the hypothesis that
phosphorylation of the immunodomi-
nant NC16A domain of collagen XVII
alters the recognition by pemphigoid
autoantibodies.
In the first set of experiments, we
assessed phosphorylation of the ecto-
domain of collagen XVII in vitro and
in vivo using an antibody (Ab) specific
for ecto-phosphorylated collagen XVII,
pSer544 (Zimina et al., 2007). This
Ab immunoprecipitated collagen XVII
ectodomain from the culture medium
(Figure 1b), demonstrating that kerati-
nocytes produce phosphorylated ecto-
domain. For immunoprecipitation,
subconfluent normal human keratino-
cytes were cultured for 24 hours, and
the medium was processed and pre-
cipitated as previously described
(Schacke et al., 1998). The proteins
were dissolved in a lysis buffer contain-
ing 1% Nonidet P-40, 0.1 M NaCl,
protease inhibitor set III (Calbiochem,
Merck KGgA Darmstadt, Germany),
phosphatase inhibitor cocktail 1 (Sigma-
Aldrich, Taufkirchen, Germany), and
25mM Tris-HCl at pH 7.4. The solution
was then subjected to immunoprecipi-
tation with the phospho-specific colla-
gen XVII Abs pSer544 overnight at 4 1C.
After extensive washing, the proteins
were eluted for 3minutes at 95 1C
with a buffer containing 0.8 M urea,
0.0001% bromphenol blue, 2% SDS,
5% glycerine, 0.01M dithiothreitol,
0.1 M Tris-HCl, pH 6.8, and immuno-
blotted with NC16A-3 Abs (Seppanen
et al., 2007). In vivo, the ectodomain of
collagen XVII was recovered from suc-
tion blisters (n¼12) induced on normal
healthy skin (Figure 1c, lower panel)
and BP blisters (n¼ 12, Figure 1d, lower
panel) by immunoprecipitation with the
mAb NC16A-1, which recognizes an
epitope within the stretch of amino acid
residues 513–525 (SC Hofmann et al.,
unpublished). The phosphorylated
form of the collagen XVII ectodomain
was immunoprecipitated by pSer544
from three suction blisters and five BP
blisters (Figure 1c and d, upper panels).
For this, 200ml of blister fluid were
dialysed against phosphate-buffered
saline using the Mini dialysis kit with
8 kDa MWCO (GE Healthcare, Munich,
Germany) for 4 hours at 4 1C and
subjected to immunoprecipitation with
the Abs pSer544 and NC16A-1, as
described above.
Although these data strongly suggest
that the production of phosphorylated
collagen XVII ectodomain is a physio-
logical event in vivo, they do not rule
out an involvement of autoantigen
phosphorylation in the pathogenesis of
BP. Collagen XVII phosphoepitopes
colocalize with immunodominant epi-
topes of BP and PG within the NC16A
domain supporting a role for phospho-
rylation in autoepitope recognition. To
determine the impact of phosphory-
lation on the reactivity of BP sera
with these epitopes, we compared
the binding of circulating BP auto-
antibodies with phosphorylated and
dephosphorylated collagen XVII. For
this, subconfluent HaCaT cells were
lysed and treated with l-phosphatase
as described (Zimina et al., 2007).
Lysates were immunoblotted with
polyclonal NC16A and monoclonal
NC16A-3 Abs, anti-phospho MAPK
p42/p44 Ab, and autoimmune sera of
16 BP patients. The sera were positive
in ELISA for the immunodominant
NC16A region (Hofmann et al., 2002)
and in indirect immunofluorescence
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analysis for reactivity with collagen
XVII. Semiquantitative densitometry
was performed with the Gel-Pro Express
4.0 software (Media Cybernetics Inc.,
Marlow, UK). Interestingly, dephos-
phorylation of the extract resulted in
a decrease of antigen recognition by 14/
16 BP sera (Figure 2a and c, Figure S1).
Seven serum samples exhibited a strong
decrease in binding to collagen XVII
and displayed only 10–20% of the
initial reactivity. In case of further
seven sera, the reactivity was reduced
to 20–50% of the initial values. One
serum sample showed a slightly dimin-
ished reactivity with dephosphorylated
collagen XVII, and one serum sample
showed no difference in the recognition
of phosphorylated and dephosphory-
lated forms of collagen XVII (Figure 2c).
Monoclonal and polyclonal Abs against
the NC16A domain (Schumann et al.,
2000; Seppanen et al., 2007) were used
as controls; they did not show any
difference in binding to phosphorylated
or dephosphorylated forms of collagen
XVII (Figure 2a). The Ab pSer544 speci-
fically immunoprecipitated the phos-
phorylated form of collagen XVII
(Figure 2b). For immunoprecipitation,
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Figure 1. The phosphorylated ectodomain of collagen XVII is found in keratinocyte cultures in vitro and in blister fluids in vivo. (a) Amino acid (AA) sequence
of the immunodominant NC16A domain of collagen XVII. Ecto-CK2 consensus sequence, amino acids 541–547, is boxed and the phosphorylated Ser544 is bold.
(b) The phosphorylated 120 kDa ectodomain is present in culture medium of normal human keratinocytes (arrow); M, culture medium as starting material;
1, fraction not bound by immunoprecipitation with polyclonal NC16A Ab; 2, fraction eluted after immunoprecipitation with NC16A Ab; 3, fraction not
bound by immunoprecipitation with pSer544 Ab; 4, fraction eluted after immunoprecipitation with pSer544 Ab. (c, d) The 120 kDa ectodomain of collagen
XVII was immunoprecipitated with pSer544 from blister fluids of 12 suction blisters (c) and 12 BP blisters (d) (c, d, upper panels) and the mAb NC16A-1
(c, d, lower panels).
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subconfluent HaCaT cells were lysed,
treated with l-phosphatase as reported
previously (Zimina et al., 2007), and
subjected to immunoprecipitation with
the phospho-specific collagen XVII
pSer544 as described above. Serum
samples of 20 healthy individuals
were included as negative controls;
they displayed no reactivity with either
form of collagen XVII. Taken together,
these observations suggest that BP
autoantibodies preferentially recognize
phosphorylated collagen XVII.
This study demonstrates that synth-
esis of phosphorylated collagen XVII
is a physiological event in vivo and
that autoantibodies in a majority of
BP patients preferentially recognize the
phosphorylated ectodomain of collagen
XVII. This observation is in line with
investigations showing increased auto-
antibody reactivity with phosphorylated
autoantigens in systemic lupus erythe-
matosus (Satoh et al., 1994; Utz et al.,
1997; Neugebauer et al., 2000; Terzo-
glou et al., 2006). Phosphorylation of
the systemic lupus erythematosus auto-
antigen La/SSB is catalyzed by intra-
cellular CK2 and leads to higher recog-
nition by autoantibodies (Terzoglou
et al., 2006). Ecto-CK2 is a key enzyme
in the phosphorylation of collagen XVII
(Zimina et al., 2007). These findings
further emphasize the importance of
CK2-like activities in the generation
of immunodominant epitopes in
autoimmune diseases. However, the
mechanisms leading to the breaking of
self-tolerance in BP still remain unclear.
Development of autoantigenicity may
begin with the recognition of post-
translational modifications by T cells
(Anderton, 2004), and phosphorylation
may create neo-epitopes (van Stipdonk
et al., 1998). Phosphorylation of the
NC16A domain may contribute to the
generation of autoantibodies against this
region and thereby influence the patho-
genesis of BP. It is tempting to speculate
that a shift in the equilibrium of phos-
phorylated versus unphosphorylated
collagen XVII ectodomain contributes
to the initiation of the pathogenic
autoimmune response(s) in BP. How-
ever, the possibility cannot be excluded
that phosphorylation of collagen XVII
ectodomain represents a compensatory
mechanism to increase cell–matrix
adhesion as a reaction to blistering
induced by BP autoantibodies and that
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Figure 2. Ectophosphorylation alters the binding of BP autoantibodies to collagen XVII. (a) l-Phosphatase treatment of HaCaT keratinocyte extracts diminished
the reactivity of BP serum autoantibodies to collagen XVII, but not the reactivity of the mAb NC16A-3 and the polyclonal Ab NC16A on immunoblots.
(þP): before l-phosphatase treatment; (P) after l-phosphatase treatment. Representative immunoblots with BP sera of patients 1 and 2 (blots with BP sera
of patients 3–16 are shown in Figure S1). As an indicator for dephosphorylation efficiency, anti-phospho MAPK p42/p44 Ab was used. (b) The phosphoepitope-
specific Ab pSer544 specificallyP immunoprecipitates phosphorylated collagen XVII from keratinocyte extracts (left panel, arrow). (þP): before l-phosphatase
treatment; (P) after l-phosphatase treatment. Phosphatase treatment does not influence the amount of collagen XVII in HaCaT keratinocyte extract,
as shown by immunoblotting with the mAb NC16A-3 (right panel). (c) Loss of phosphoepitopes in collagen XVII resulted in significantly decreased
reactivity of 14/16 (88%) BP sera. The serum samples were tested on immunoblots as shown in panel a, and the intensity of the bands was quantitated
by densitometry. The columns indicate the relative reactivity of the serum with dephosphorylated versus phosphorylated collagen XVII.
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the phosphoepitope Abs result from
epitope spreading. A different constella-
tion relevant in this context was inves-
tigated by Liu et al. (1993) who used
passive transfer of Abs into mice to
induce skin blistering. The Abs had
been raised against recombinant pro-
karyotic non-phosphorylated NC16A
fragments, and one could argue that
phosphorylation is not required for
blister formation. However, blister
formation in the mouse model and the
initiation of autoantigenicity in human
disease may not be directly comparable,
as other factors and mechanisms are
most likely to influence the initial steps
in the pathogenesis of human BP.
Further investigations must clarify these
questions. The study was conducted
according to the Declaration of Helsinki
Principles. Informed consent was ob-
tained from the patients described in
this paper.
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SUPPLEMENTARY MATERIAL
Figure S1. Loss of phosphoepitopes in collagen
XVII resulted in decreased reactivity of BP sera.
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